<http://webisa.webdatacommons.org/prov/445525784>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/177917626> .
<http://webisa.webdatacommons.org/177917626>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/177917626>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<biotechdaily.com> .
<http://webisa.webdatacommons.org/177917626>	<http://www.w3.org/ns/prov#value>	"A consortium of biotech companies will promote the use of modified recombinant antibodies for use in the development of monoclonal antibody-based therapeutics to fight cancer and other life-threatening and debilitating diseases." .